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Maine Medical Center is contin-
uously putting patients and fami-
lies first by investing in our three-
part mission: Caring for our 
community, Educating tomor-
row’s caregivers, Researching new 
ways to provide care. Now we’re 
taking time to highlight the hard 
work of specialties which live 
that mission. For eight issues of 
What’s Happening, we’ll 
share how each specialty is ex-
ceeding national standards of 
patient care through hard work 
and dedication, as recognized by 
the U.S. News and World 




MMC’s pulmonary program 
is part of the national 
ARDS (Adult Respiratory 
Distress Syndrome) net-
work for  research, working 
to provide the best care for 
our critically ill patients. 
Pulmonary works closely 
with the hospital’s critical 
care staff. The combined 
team, the Pulmonary and 
Critical Care Medicine Divi-
sion, has provided educa-
tion for internists looking 
to become specialists for 
more than 20 years. The 
fellowship program is the 




tively with Chest Medicine 
Associates (CMA), is dedi-
cated to quality patient care, 
innovative education, and 
front-line research that pro-
duces real results for our 
community, region, and 
nation,” says Joel Wirth, 
M.D., Division Director, 
Pulmonary and Critical 
Care Medicine. 
 
In addition to achieving a 
working collaboration with 
critical care, MMC’s Pulmo-
nary program has achieved 
great success for our pa-
tients and on a global level, 
particularly in three areas: 
 Advanced broncho-
scopy and diagnostics 




Mayuko Fukunaga, M.D., 
leads the Advanced Bron-
choscopy and Diagnostics 
Program, which provides 
exceptional diagnostics and 
therapeutic endoscopic lung 
procedures. MMC is the 
only hospital in Maine of-
fering Electromagnetic 
Navigation bronchoscopy 
(EMN), which can reduce 
the need for diagnostic  
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The final steel beam of 
Bean 2, our new surgical 
unit, was lifted into place 
last week — a process 
called “topping out”  —
completing the structural 
phase of construction. The 
beam was signed by hun-
dreds of employees, many 
of whom will work in the 
new space.  
 
The pine tree and flag atop 
the beam is a long-held 
builders’ tradition, symbol-
izing the successful, safe 
framing of the structure and 
continuing good luck.  
Topping Out 
David Chalmers, M.D., 
has joined Maine Medical 
Partners – Urology in South 
Portland. He comes to 
Maine from Denver, CO 
where he completed a pedi-
atric urology fellowship at 
Children’s Hospital of Col-
orado. Dr. Chalmers re-
ceived his medical degree 
from Wake Forest School 
of Medicine in 2007 and 
underwent residency at The 
University of Connecticut.   
 
The Baltimore Sun Mary-
land High School Runner of 
the Year in 1996, and a two-
time Dartmouth Cross 
Country captain, Dr. 
Chalmers is looking forward 
to exploring Maine’s many 
running trails. 
Matthew R. Sanborn, 
M.D., has joined Maine 
Medical Partners – Neuro-
surgery & Spine.  
 
Fellowship-trained in endo-
vascular neurosurgery, Dr. 
Sanborn joins the cerebro-
vascular/endovascular team 
at MMC, specializing in the 
treatment of aneurysms, 
AVMs, carotid vertebral 
disease, and stroke. 
  
Dr. Sanborn received his 
medical degree from 
Georgetown University 
School of Medicine. He 
completed his residency at 
Hospital of the University 
of Pennsylvania and his fel-
lowship at Barrow Neuro-
logical Institute. An avid 
skier and mountaineer, he is 
a member of the Wilderness 
Medicine Society. 
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chest surgery for certain 
patients, and the program 
offers the only Cardiopul-
monary Exercise Testing 
(CPET) in the region. 
 
MMC is leading the state in 
providing comprehensive 
care for adults with Cystic 
Fibrosis (CF) through the 
Adult Cystic Fibrosis Cen-
ter, led by Jonathan Zucker-
man, M.D. The MMC CF 
Center is part of the Cystic 
Fibrosis Foundation’s Ther-
apeutics Development Net-
work (TDN). Through effi-
cient study design, opti-
mized clinical trial execu-
tion, and high-quality data, 
the TDN helps speed the 
delivery of new and better 
therapies to people with CF. 
Dr. Zuckerman and Ted 
Sears, M.D., have won com-
petitive national grants to 
support their CF research. 
 
Pulmonary Arterial Hyper-
tension (PAH) is a rare but 
often fatal disease for which 
there is no cure. Together, 
MMC and CMA were one 
of the first programs to pro-
vide highly specialized, mul-
ti-disciplinary care for PAH 
patients throughout North-
ern New England. The pro-
gram has helped to develop 
several of the new drugs 
that are now available to 
treat PAH, and survival for 
patients with PAH has dou-
bled in the last five years as 
a result of new drugs. 
 
“Our program has long held 
a leadership role in improv-
ing the lives of those with 
pulmonary disease,” says 
Dr. Wirth. “Through partic-
ipating in the development 
of new drugs, our advanced 
pulmonary diagnostics pro-
gram, educational opportu-
nities, and our commitment 
to providing 24/7 in-house 
attending-level care for criti-
cally ill patients, we are able 
to enhance the lives of 
some of our most critical 
patients and patients across 
the country.”  
David Chalmers, M.D. Matthew Sanborn, M.D. 
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